Advertisement

Topics

Latest "Cell Design Labs Appoints Chief Medical Officer" News Stories

07:50 EDT 21st August 2018 | BioPortfolio

Here are the most relevant search results for "Cell Design Labs Appoints Chief Medical Officer" found in our extensive news archives from over 250 global news sources.

More Information about Cell Design Labs Appoints Chief Medical Officer on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cell Design Labs Appoints Chief Medical Officer for you to read. Along with our medical data and news we also list Cell Design Labs Appoints Chief Medical Officer Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cell Design Labs Appoints Chief Medical Officer Companies for you to search.

Showing "Cell Design Labs Appoints Chief Medical Officer" News Articles 1–25 of 35,000+

Tuesday 21st August 2018

Capital Health uses FDA-approved Embotrap II stent retriever for ischemic stroke patients

As part of its Comprehensive Stroke Center, neurosurgeons from Capital Health’s Capital Institute for Neurosciences use this next generation stent-retriever to safely remove a blood clot from an The post Capital Health uses FDA-approved Embotrap II stent retriever for ischemic stroke patients appeared first on Compelo Medical Devices.


UCHealth conducts first patient procedure using Sterizone technology

TSO3, a provider of sterilization technology for medical devices in healthcare settings, secured 510(k) clearance from the US Food and Drug Administration (FDA) for the terminal sterilization of The post UCHealth conducts first patient procedure using Sterizone technology appeared first on Compelo Medical Devices.

CareFirst, Exagen Diagnostics to study impact of Avise Lupus diagnostic test

As part of the agreement, select CareFirst members will have access to the Avise Lupus test to aid in the differential diagnosis of systemic lupus erythematosus (SLE). SLE The post CareFirst, Exagen Diagnostics to study impact of Avise Lupus diagnostic test appeared first on Compelo Medical Devices.


Qualyst Transporter Solutions LLC Medical Equipment Deals and Alliances Profile [Report Updated: 12062018] Prices from USD $250

SummaryQualyst Transporter Solutions LLC Qualyst Transporter Solutions, formerly Qualyst Inc is a provider of hepatic drug transporter products and contract research services using BCLEAR technology. The company offers products such as transporter certified products, transporter interactions, hepatic exposure, P450 inhibition, and transporter induction, biliary excretion, hepatotoxicity kits, bile...

NovaBay Pharmaceuticals Inc NBY Medical Equipment Deals and Alliances Profile [Report Updated: 12072018] Prices from USD $250

SummaryNovaBay Pharmaceuticals Inc NovaBay, formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company's products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid and lash hygiene spray solution helps in removal of foreign materials such as microorganisms and debris ...

BellBrook Labs Launches New Streamlined Website

Bellbrook Labs is pleased to announce the launch of their exciting new website. An updated design and layout now offers more streamlined customer interaction, making learning more about BellBrook’s products, services, and therapeutic pipeline even easier. MADISON, Wis. (PRWEB) August 21, 2018 Whether it be online or through a suite of high throughput screening (HTS) solutions, Bellbrook Labs is...

MBio Diagnostics, Inc. Announces Additional $6 Million in Series B Funding

Funding Supports Scaling of Portable On-the-Spot Testing Platform MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, announced an additional $6 million in Series B financing led by new and existing investors, including MBio’s recently announced strategic veterinary partner, Heska. ...

Ichor Medical Systems Announces Utilization of Its Investigational TriGrid Delivery System in a Clinical Trial Evaluating GX-188E Vaccine Combined with a Checkpoint Inhibitor for Treatment of Cervical Cancer

Ichor Medical Systems, Inc. (Ichor) announced today that its investigational TriGrid® Delivery System (TriGrid) is being utilized in a Phase 1b/2 clinical trial to administer GX-188E, an investigational therapeutic HPV DNA vaccine developed by Genexine, I

Largest Brain Study of 62,454 Scans Identifies Drivers of Brain Aging

Schizophrenia, cannabis use, and alcohol abuse are just several disorders that are related to accelerated brain aging In the largest known brain imaging study, scientists from Amen Clinics (Costa Mesa, CA), Google, John’s Hopkins University, University of California, Los Angeles and the University of California, San Francisco evaluated 62,454 brain S...

Renovia Completes $42.3 Million Series B Financing

Financing Will Accelerate Clinical Research, Development and New Digital Therapeutic Device Launches Targeted at Pelvic Floor Disorders Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced the close of $42.3 million in...

Imago BioSciences Completes Enrollment in Phase 1/2a Study of IMG-7289 in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Imago BioSciences, a clinical-stage pharmaceutical company developing novel anti-cancer therapies, announced today that the Phase 1/2a clinical trial of IMG-7289 for the treatment of high-risk acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) has fully enrolled at 45 patients. This study assessed the safety, pharmacokinetics, pharma...

Co-Diagnostics Announces Filing of S-3 Shelf Registration

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today the filing of a shelf registration statement on Form S-3 with the Securities and Exchange Commission (“SEC”) to sell up to an aggregate amount of $25 million of its shares, which amo...

Sverica Capital Management Announces Acquisition of Gener8, LLC

Sverica Capital Management LP (“Sverica”) today announced that it had acquired a majority interest in Gener8, LLC (“Gener8”). The investment marks Sverica’s sixth investment from its fourth fund. Based in Sunnyvale, CA, Gener8 designs and manufactures

Pfizer’s lorlatinib clears first hurdle to UK early access scheme

Pfizer’s lorlatinib has been designated a Promising Innovative Medicine for the treatment of some patients with ALK-positive advanced non-small cell lung cancer.

John ‘Zeke’ Czekanski, Global Commercial Head, Leaves Fishawack

In consultation with John ‘Zeke’ Czekanski, Fishawack has mutually and amicably agreed that he will transition out of the business as we evolve our structure to accommodate the growth of the organization and recent acquisitions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180821005132/en/

Advanced MultiFlo™ FX Capabilities Enhance Cell Biology Applications

BioTek Instruments announces enhancements to the MultiFlo™ FX Multi-Mode Dispenser to facilitate cell biology workflows. MultiFlo FX has a modular design that makes it easy for users to add functionality that benefits their unique applications. The new, patent-pending AMX™ Automated Media Exchange  module automates gentle, consistent media exchanges to protect and encourage c...

Scientists discover first step towards finding a new, targeted lung cancer treatment

Press release Scientists have identified a key molecular player in a subtype of lung cancer which could lead to a new way to tackle the disease, according to research published in Nature Communications. “How LUSC develops is a bit of puzzle – until now our molecular understanding of this process was limited. Our research has revealed a major piece of this puzzle, which we are now actively...

Physician Burnout CME Conference: Yoga Science as Holistic Mind/Body Medicine

The American Meditation Institute (AMI) will host its 10th annual comprehensive training in Yoga Science as holistic mind/body medicine conference October 23-27, 2018 at the Cranwell Resort and Spa in Lenox, Massachusetts. This 32 credit CME training, which is accredited by the American Medical Association, will provide a proven curriculum that transforms the energy of stress, and furnish each att...

RDMD secures seed funding to advance disease research and drug development platform

RDMD has received funds under the seed financing round led by Lux Capital, and participants include Village Global, First Round’s Healthcare Co-Op, Garuda, Shasta Ventures and various angel The post RDMD secures seed funding to advance disease research and drug development platform appeared first on Compelo Medical Devices.

Navamedic ASA: Renews multiple key distribution agreements

    Oslo, August 21, 2018 - Navamedic ASA (OSE: NAVA) today announced it has renewed three partnership agreements with Vitaflo International Limited, Allerderm Laboratories and Qiagen GmbH for continued Nordic distribution of important products within medical nutrition, dermatology and women's health.   "We are very pleased to announce a renewal of our partnerships with Vita...

Acarix Interim Report, January - June 2018 : Acarix gains traction in key markets providing physicians and patients new opportunities

Interim Report, January - June 2018 Malmö, August 21, 2018 Acarix gains traction in key markets providing physicians and patients new opportunities "Since the inception of Acarix, the company has been fully committed to developing a reliable, non-invasive and radiation-free method to rule out stable Coronary Artery Decease (CAD) based on ultrasensitive phonocardiography. During t...

MeVis Medical Solutions AG: MeVis publishes figures for the third quarter of fiscal year 2017/2018

DGAP-News: MeVis Medical Solutions AG / Key word(s): Interim Report/9-month figures 21.08.2018 / 08:00 The issuer is solely responsible for the content of this announcement. As expected, decline in sales also in the third quarter Revenues at EUR 3.9 million approximately 12 % below previous year's level EBIT of EUR 4.4 million in the first nine months (compared to EUR 5.3 million in...

AMRX Soars On Contract Win, TRPX Looks Ahead With Hope, ALXN To Face FDA In Feb

Today's Daily Dose brings you news about Amneal Pharma's contract with Jerome Stevens; Alexion Pharma's regulatory catalyst in February 2019; FDA's expanded approval for Merck's Keytruda; ProPhase Labs' improving financials and Therapix Biosciences' anticipated milestones.

Measles Cases Hit Record High in Parts of Europe

The World Health Organization calls on countries to immediately implement broad, context-appropriate measures to stop the further spread of measles following a dramatic increase in infections. Medscape Medical News

Prism Medical Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 16052018] Prices from USD $250

SummaryPrism Medical Ltd Prism Medical, a subsidiary of Handicare AB is a medical device company that manufacturer and provides durable medical equipment. The company offers products such as fixed ceiling lifts, portable ceiling lifts, portable track systems, mobile floor lifts, sling systems, home medical equipment, bed repositioning and transfer, shower chairs, moving and handling products, trac...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks